🇮🇳

India Market Intelligence

· daily

India IPO Pipeline SEBI Regulatory Filings — October 28, 2026

This stream covers India IPO Pipeline events, but the single filing supplied is a Route Mobile Limited board-results and dividend announcement rather than an IPO filing, approval, or listing event. Route Mobile's quarter and half-year results (ended September 30, 2026) were approved with limited review from MSKA & Associates LLP, though headline revenue and profit figures are not disclosed in the text provided. The company declared a second interim dividend of ₹4 per share (40% of ₹10 face value) with a November 2, 2026 record date, and reversed its May 7, 2026 decision to redeploy ₹650 million of unutilised IPO proceeds, which stays earmarked for Mumbai office premises. No period-over-period comparisons, forward guidance, or insider transaction data were available in the enriched fields for this filing, so trend and outlier analysis across companies is not possible. The overall sentiment is neutral with materiality rated 6/10. The most actionable element is the dividend timeline and the trading-window opening on October 30, 2026, which may be relevant to designated persons and to income-focused investors tracking this IPO-listed name.

1 high priority 1 total filings
· daily

India RBI Banking Regulatory Enforcement Actions — October 28, 2026

This digest covers two RBI supervisory actions issued under Section 35A read with Section 56 of the Banking Regulation Act, 1949, both against small cooperative banks (Lokapavani Mahila Sahakari Bank, Mandya, and Sonpeth Nagari Sahakari Bank, Parbhani). Both filings are extensions of existing directions rather than new penalties, signalling that supervisory restrictions on these institutions remain in force and that RBI is not yet satisfied with their financial position. The filings contain no period-over-period financial figures, insider activity, capital allocation, or forward-looking guidance, so quantitative trend analysis is not possible from the enriched data. The portfolio-level pattern is one of prolonged supervisory oversight of weak urban cooperative banks, with the Lokapavani extension explicitly stating it does not imply satisfaction with the bank's finances. Market implications are limited to sentiment for the cooperative-bank segment and deposit-confidence risk for the named institutions, which are not listed equities, so direct investment actionability is low.

2 medium 2 total filings
· daily

India BSE NSE Trading Suspension Orders — October 28, 2026

The stream 'India Trading Suspensions & Delistings' (scope: Regulatory Action, 28 Oct 2026) contains four filings, of which three are in scope. The common thread is regulatory and legal process rather than trading suspensions: an NCLT-approved capital reduction at Phoenix Mills' subsidiary, a SEBI adjudication order against Swaraj Shares and Securities, and an NCLAT interim direction that stops MSCI from delisting Polycab India from its index pending a reserved insolvency appeal. Adani Enterprises is the most material filing (materiality 8/10) and is the one with quantitative period-over-period data: consolidated Q2 FY27 revenue rose 75.2% YoY to ₹37,215.62 Cr while Q2 PAT fell 64.2% to ₹1,220.99 Cr, and half-year PAT swung to a loss of ₹(240.55) Cr after a ₹2,644.02 Cr OFAC settlement charge in Q1. Balance-sheet metrics improved, with consolidated net worth at ₹103,713.28 Cr (up from ₹89,178.22 Cr at 31-03-2026) and debt-to-equity easing to 0.94 from 0.97, and a ₹15,000 Cr QIP is pending. The filings provide no insider-trading, dividend or buyback data, so conviction signals are limited to what the filings state. Key near-term items are the certified NCLT order filing and 30-day cash payment for Phoenix Mills, the full SEBI order text, and the NCLAT pronouncement in the Polycab matter.

4 high priority 4 total filings
· daily

India NCLT Insolvency Resolution Filings — October 28, 2026

Across the nine filings for the India Corporate Insolvency & NCLT stream dated 28 October 2026, the dominant theme is post-insolvency capital restructuring: several companies are using NCLT/NCLAT-approved or board-approved capital reductions, cancellations and preferential issues to extinguish or radically dilute legacy shareholders, with public float collapsing in the Talwalkars and Ashapura cases. The enriched data is largely procedural in nature: most filings contain no period-over-period financial figures, guidance, or insider transaction data, so quantitative trend analysis is limited and the conclusions rest mainly on the structural terms of the transactions. The most material developments are the Talwalkars Better Value Fitness restructuring (promoter stake rising from 32.89% to 95.00% via a 95,00,000-share preferential allotment to the Managing Director as nominee, with public holding falling from 67.11% to 5.00%) and the Ashapura Intimates capital reduction that wipes out the entire promoter holding of 14.76%. Gujarat Toolroom carries the highest materiality (9/10) but its filing is a Public Announcement with no usable financial data, and the Polycab filing signals a live appeal that could affect index inclusion in the near term. Near-term catalysts cluster around 29 October (BIL Vyapar CoC meeting and VXL IMC meeting) and 27 November (POCL Enterprises shareholder and creditor meetings), while the Polycab NCLAT ruling and the Talwalkars regulatory approvals remain open-ended. Portfolio-level, the pattern is that insolvency outcomes are concentrating control with incoming investors or nominees and leaving minority public shareholders with very small residual stakes.

9 high priority 9 total filings
· daily

India Monetary Policy RBI MPC Decisions — October 28, 2026

This session covers a single RBI money market operations release for October 27, 2026, which is a routine liquidity update rather than a policy rate change, so the 'Rate Change' scope is only loosely met. The data show overnight market volume of ₹7,17,097.85 crore at a weighted average rate of 5.64%, with a net liquidity absorption of ₹30,419.13 crore after outstanding operations and a net absorption of ₹1,65,213.00 crore on the day. Standing Deposit Facility placements of ₹1,72,235.00 crore at 5.25% and Marginal Standing Facility usage of ₹7,022.00 crore at 5.75% frame the policy corridor in which overnight rates are trading. Cash reserves of ₹8,47,673.99 crore exceeded the average daily requirement of ₹8,33,309.00 crore for the fortnight ending October 31, 2026, indicating comfortable bank liquidity. Net durable liquidity stood at a surplus of ₹10,14,401.00 crore as of September 30, 2026, consistent with an accommodative liquidity backdrop. Overnight rates ranged from 4.30% to 6.00% across segments, with the upper end concentrated in Repo in Corporate Bond. The filing carries a neutral sentiment and low materiality (4/10), and no period-over-period comparisons, insider activity, capital allocation, or forward guidance were provided in the enriched data.

1 high priority 1 total filings
· daily

India Sector Consolidation Regulatory Filings — October 28, 2026

The 21 filings in this stream span a wide mix of corporate actions, but only a subset are genuinely M&A, consolidation, scheme, or takeover events; several (Hero MotoCorp's subsidiary funding, Titan's new Canadian incorporation, Oswal's Dubai JV, Meesho's AI subsidiary investment, KPIT's routine approvals) are better described as group restructuring or capital infusion rather than sector consolidation. The most material consolidation developments are TVS Motor's composite scheme (amalgamation plus demerger of a roughly Rs 3,921 Cr consumer finance business, about 11% of turnover, with a 1:1 share entitlement) alongside its Rs 25,000 acquisition of Harita ARC and Rs 530.08 Cr purchase of STPL Trading, which together reshape its financial services footprint. Emkay Global's transfer of its asset management and wealth subsidiaries (about 6.12% of consolidated income in FY26) and Phoenix Mills' Rs 1,350 Cr buyout of CPP Investments' stake in ISMDPL (lifting its holding from 58.33% to 68.10%) are the other clear consolidation plays. Period-over-period data is strongest at Aeroflex (consolidated Q2 revenue up about 42.7% YoY, EPS Rs 2.76 vs Rs 1.10) and Prudent Corporate (Q2 standalone revenue up about 25.5% YoY), but both show cost pressure, with Aeroflex's cost of materials up 74.2% and Prudent's employee costs up about 30.7% in H1. Subsidiary-level signals are mixed: Eclerx's target Personiv shows turnover falling from Rs 1,218 mn (FY24) to Rs 187 mn (FY26), and Fortis's acquired Suguna hospital shows flat revenue of about Rs 50 Cr across FY24-FY26. Note that the enriched insider, capital allocation, and forward-looking fields are largely absent from these summaries, so quantitative comparisons are limited to what the filings disclose.

17 high priority 4 medium 21 total filings
· daily

India Digital Infrastructure Telecom Regulatory Filings — October 28, 2026

All three filings originate from a single issuer, Satin Creditcare Network Limited (NSE: SATIN, BSE: 539404), a microfinance and housing finance group. The stream's technology/digital-infrastructure scope is only loosely matched: Satin is a financial services company, and none of the three filings touches 5G, broadband, fiber, spectrum, or telecom infrastructure. They are retained only because the instruction was to keep filings in scope when in doubt and because the filings fall under the Market Notice event type, so the insights below should be read as an off-theme signal rather than digital-infrastructure intelligence. Period-over-period results were exceptionally strong: consolidated H1FY27 PAT of Rs 299 Crore rose 204% YoY, standalone H1 PAT rose 209% to Rs 292 Crore, and Q2FY27 PAT of Rs 176 Crore (up 231% YoY) was the company's highest ever, nearly reaching FY26 full-year profit of Rs 332 Crore. Growth was driven by disbursements (+48% in H1; consolidated Q2 disbursement of Rs 3,697 Crore, +41%) and AUM (consolidated Rs 16,589 Crore, +31% YoY). However, the picture is mixed: a Rs 50 Crore management overlay diluted ROA and ROE (reported standalone 4.3%/17.8% vs 4.8%/20.1% excluding it), the presentation shows an internally inconsistent consolidated AUM comparison across Q1 and Q2, annualised AUM growth of about 19% trails management's own FY27 guidance of 20-25%, and the on-book GNPA of 1.94%, though improved, still warrants monitoring. A preferential warrant proceeds monitoring report showed no deviation, a low-materiality governance confirmation.

3 medium 3 total filings
· daily

BSE IT Technology Sector Regulatory Filings — October 28, 2026

Across the 15 filings for the S&P BSE IT constituent stream (dated 2026-10-28), the dominant theme is a split between top-line stability and margin or cash pressure. KPIT Technologies is the most data-rich name: Q2 FY27 revenue rose 6.5% YoY to ₹16,909.66M and 0.9% QoQ, but consolidated profit fell 28.6% YoY to ₹1,206.57M as employee costs (+10.1% YoY) and forex losses outran revenue, and net cash dropped from ₹9.0B to ₹6.2B on dividends and working capital. Infosys is the most market-significant development: management cut FY27 constant-currency growth guidance to 1%-2% from 1.5%-3%, even as AI revenue reached 10.5% of revenue and TCV was $5.2bn, pointing to volume softness and pricing pressure rather than demand collapse. Cyient shows the same bifurcation, with DET EBIT margin at a 10-quarter high of 14.2% but organic DET revenue growing only 1.6% QoQ, with growth carried by the acquired TAO Digital. Governance and corporate-action filings (KPIT board approvals, LTM NDR notice, Coforge sponsorship, HCL nano-GCC launch) are largely neutral and low-materiality, with GCC-focused product launches from LTM and HCL being the most notable strategic signals. Portfolio-level, the sector is trading growth for margin defense and capital return, and near-term catalysts hinge on guidance credibility and Q3 margin trajectories.

4 high priority 11 medium 15 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — October 28, 2026

The 18 filings for the S&P BSE SENSEX 30 stream on 2026-10-28 are dominated by two Sensex constituents: Adani Ports and Special Economic Zone (APSEZ) and Hindustan Unilever (HUL), with the rest comprising earnings-calendar notices from Power Grid, NTPC and Bharti Airtel, a Titan subsidiary incorporation, an Infosys guidance cut, and an HCL Technologies product launch. Top-line momentum is strong at APSEZ (consolidated revenue up ~24% YoY to ₹11,340 Cr) and HUL (USG 15%, highest in 14 quarters, UVG 7%), but earnings quality is weaker than headlines suggest: APSEZ standalone PAT fell ~40% sequentially and Logistics EBITDA grew only 8% on 21% revenue growth, while HUL's EBITDA margin contracted 140 bps to 22.6% and reported PAT was flat YoY because of a one-off ₹273 Cr tax gain in the base period. Infosys is the clearest negative, cutting FY27 constant-currency revenue growth guidance to 1-2% from 1.5-3% on softer volumes and pricing pressure, even as AI revenue rose to 10.5% of revenue and large-deal TCV reached $5.2 bn. The dominant portfolio pattern is growth driven increasingly by price/mix and high-margin pockets rather than broad volume expansion, with mixed sentiment on most of the material filings. Near-term catalysts cluster around the 1 November 2026 Power Grid board meeting, the 31 October NTPC call, the 6 November Bharti Airtel call, and HUL's ₹19 interim dividend (record date 12 November).

6 high priority 12 medium 18 total filings
· daily

India MCA Corporate Compliance Enforcement — October 28, 2026

This digest covers a single pre-analyzed filing for the 'India MCA Compliance & Enforcement' stream, dated October 28, 2026. The only filing is a SEBI adjudication order concerning Swaraj Shares and Securities Private Limited, which is a securities-market enforcement action rather than an MCA (Ministry of Corporate Affairs) or Companies Act prosecution. The filing excerpt contains only the title and header, so the violations alleged, penalty quantum, and final outcome cannot be determined. No period-over-period financial comparisons, insider transactions, forward-looking guidance, capital allocation events, or transaction details are available in the enriched data, so portfolio-level trend analysis is not possible. The only actionable item is the need to retrieve the full adjudication order to assess materiality and any directions issued. Because the filing sits at the boundary of the stream's scope (SEBI enforcement, with 'enforcement' and 'penalty' keywords matching), it is retained with caution rather than excluded.

1 high priority 1 total filings
· daily

India Merger Acquisition MCA Regulatory Filings — October 28, 2026

Across the 17 filings in the India MCA Merger & Acquisition Tracker, activity is dominated by intra-group restructurings, subsidiary capital infusions and related-party investments rather than third-party M&A, with a handful of material transactions standing out. The most consequential developments are Phoenix Mills' NCLT-approved buyout of CPP Investments' 41.67% stake in ISMDPL (cash consideration Rs 1,350 Cr, lifting its stake to 68.10%), Emkay Global's material transfer and slump-sale restructuring of its wealth and asset-management businesses (about 7.25% of consolidated income in EIML alone), and Fortis Healthcare's all-cash ~Rs 277 Cr Bengaluru hospital acquisition. Aeroflex Industries shows the strongest reported operating momentum, with Q2 FY27 consolidated revenue up 42.7% YoY and EPS of Rs 2.76 versus Rs 1.10, though its input-cost growth (+74.2%) and a sharp drop in bank balances warrant scrutiny. Several filings are mixed: Prudent Corporate's revenue grew ~25.5% YoY but employee costs rose ~30.7% for H1, and Eclerx's target entity shows steadily declining turnover (Rs 1,218 Mn in FY24 to Rs 187 Mn in FY26). Note that Meesho, KPIT and Info Edge filings omit headline financials, so period comparisons there cannot be assessed. Insider and pledge data are largely absent from these filings, so management conviction signals rely mainly on the scale and direction of capital deployment.

14 high priority 3 medium 17 total filings
· monthly

India Pre-Market Regulatory Roundup — October 28, 2026

Across 50 overnight filings for 27-28 October 2026, the dominant theme is a sharp divergence between top-line growth and bottom-line conversion. Several issuers posted strong revenue growth (Waaree Energies H1 revenue +47% YoY; Piramal Pharma consolidated revenue +23% YoY in H1; Unimech consolidated revenue +98% YoY in Q2), yet margins and profits lagged, as seen at Waaree (Q2 EBITDA margin 17.8% vs 23.2%, PAT margin 9.8% vs 14.1%), Syngene (Q2 PAT before exceptionals -43% YoY) and Siyaram Silk (Q2 PAT -13.8% YoY). Tax expense inflation (Piramal Q2 tax +44% YoY; Unimech Q2 tax +153% YoY) and falling other income (Unimech, Piramal, Star Health investment-income commentary) further compressed earnings quality. Insurance and consumer names showed mixed profile shifts: Star Health Q2 PAT of Rs 264.8 Cr was up sharply YoY but down 52% QoQ, with the claims ratio edging up to 68.95%. Capital-raising and governance activity was notable: Madhav Infra approved a Rs 49 Cr rights issue amid H1 revenue down 17% YoY, Taylormade Renewables proposed Rs 9.98 Cr of promoter warrants, and Tilak Ventures announced a 7:3 demerger. Most of the remaining filings are procedural (board-meeting notices, trading-window closures, earnings-call logistics), so the actionable flow is concentrated in roughly 15 companies with substantive numbers. Net read: growth is available, but investors should discount headline revenue and focus on margin, tax and other-income quality.

14 high priority 36 medium 50 total filings
· daily

India MCA Insolvency Liquidation Filings — October 27, 2026

The 15 filings cluster around three situations: Premier Limited's long-running CIRP with a stream of delayed Committee of Creditors (CoC) intimations, several NCLT-driven schemes of amalgamation or demerger (Privi Speciality Chemicals, Share India Securities, POCL Enterprises, EFC (I) Limited), and a routine CoC notice from CMI Ltd. The enriched period-over-period, insider, capital allocation, and forward-looking fields are empty for every filing, so no quantitative YoY/QoQ trends, guidance changes, or insider signals can be drawn; the analysis rests on procedural dates, hearing schedules, and disclosure timeliness. The most material pattern is disclosure lag: at least five Premier intimations dated October 27, 2026 report meetings held between December 2025 and October 2026, which suggests compliance weakness under Regulation 30 and warrants scrutiny of the company's governance during CIRP. Scheme-related filings carry the next time-sensitive catalysts, with November 27, 2026 hearings scheduled for both POCL Enterprises and EFC (I) Limited. Market implications are limited for now because no financial outcomes are disclosed, and most items are rated neutral with materiality of 4 to 6 out of 10.

15 high priority 15 total filings
· daily

India Corporate Governance MCA ROC Filings — October 27, 2026

This digest covers two Indian corporate governance filings dated within the stream window. Swati Projects Limited has scheduled a board meeting on 6 November 2026 to consider the resignation of director Mr. ShreeGopal Daga, a procedural notice that discloses neither the reasons for resignation nor any financial figures. Allied Blenders and Distillers Limited's board approved, subject to shareholder approval via Postal Ballot, the second five-year term of Independent Director Mr. Balaji Vishwanathan Swaminathan (February 2027 to February 2032), continuation of Mr. Nasser Mukhtar Munjee beyond age 75 until October 10, 2029, a remuneration revision for Whole-time Director Mrs. Resham Chhabria J Hemdev effective April 1, 2026, and commission and cost auditor approvals. Neither filing contains period-over-period financial comparisons, insider trading activity, capital allocation changes, or quantified forward guidance, so portfolio-level trend analysis is not possible from this data. The dominant theme is board-composition and remuneration governance rather than distress; the one item that could carry signal is the Swati Projects resignation, whose reasons remain undisclosed until the meeting outcome is filed. Materiality is low across both filings (4/10 and 3/10).

2 medium 2 total filings
· daily

India Stock Market Daily Regulatory Digest — October 27, 2026

Across 50 Indian market filings for 27 October 2026, the dominant pattern is a sharp divergence between earnings momentum and quality of earnings. Several large or mid-cap names posted strong top-line or profit growth (Morepen Laboratories with revenue up 81% and PAT up 117% YoY in Q2; Acutaas Chemicals with revenue up 41.9%; Vardhman Special Steels with revenue up 38.8%), yet many of these gains were flattered by one-offs, non-operating income, or working-capital build-up. Conversely, a cluster of companies saw meaningful deterioration: Quest Flow Controls swung to a consolidated loss of Rs 1,567 Lakh on a 14% revenue decline, Cipla's consolidated EBITDA margin contracted about 630 bps YoY to 18.7%, and Kirloskar Pneumatic's standalone revenue fell 15.4% YoY. Macro headwinds cited across filings include West Asia tensions, shipping disruptions, weak monsoon conditions (affecting NBFC credit costs at Shriram Finance) and LRS/US visa scrutiny (affecting remittance platforms). Corporate-event flow is heavy: roughly 20 routine board-meeting, trading-window, or earnings-call notices cluster between 30 October and 13 November 2026, creating a dense catalyst calendar. The single largest market-relevant event is Tata Motors' tender offer for Iveco Group, where 87.81% of offer shares were provisionally tendered at EUR 14.40, with final results due 29 October and payments on 30 October and 13 November. Several filings are thin on financial detail (governance notices, ESOP grants), so their informational value is procedural.

15 high priority 35 medium 50 total filings
· daily

India Debt Bond Securities SEBI Regulatory Filings — October 27, 2026

Across six Indian debt-market filings dated 27 October 2026, the dominant theme is routine but meaningful debt-capital activity: a sovereign-linked and bank-linked call option (Canara Bank's ₹1,500 Crore Basel III AT1 bonds), short-tenor commercial paper issuance and redemption by EPL Limited, a rating upgrade for Ashiana Housing covering roughly ₹468 Crore of NCDs, and a secured NCD programme of up to ₹300 Crore proposed by Transport Corporation of India (TCI). The most material credit development is the CARE upgrade of Ashiana Housing from A to A+ (both issuer and six NCD series), which is the only clearly positive rating action in the set. Transport Corporation of India presents the most complex picture: standalone revenue rose 13% YoY in Q2 FY27 to ₹11,850 Mn and half-year revenue grew 11%, yet Q2 net profit fell 4% YoY and half-year profit was flat at ₹2,115 Mn versus ₹2,120 Mn, while standalone borrowings more than doubled-plus to ₹2,990 Mn from ₹1,160 Mn a year earlier and capital employed rose about 25%. The implication is that TCI is growing its top line and balance sheet faster than earnings, which increases the importance of its new ₹300 Crore secured NCD issuance. Canara Bank's AT1 call exercise is a neutral, pre-announced event with prior intimations on 14.01.2026, 03.09.2026 and 04.09.2026, so it carries little surprise value. Overall the stream shows healthy issuer credit conditions at the top end of Indian bank and corporate debt, with the real analytical focus on TCI's leverage build-up and profit conversion.

2 high priority 4 medium 6 total filings
· daily

India Healthcare Pharma Policy Regulatory Filings — October 27, 2026

This India Healthcare Policy stream for 27 October 2026 contains two Regulation 30 market notices, both from Fortis Malar Hospitals Limited, covering the same board event: the resignation of Non-Executive Non-Independent Director Dr. Ritu Garg and her replacement by Dr. S Narayani, appointed by circulation at 02:25 PM. Both filings are neutral in sentiment and rated 3/10 in materiality. The enriched data provides no period-over-period financial comparisons, forward-looking guidance, insider trading or pledge activity, capital allocation changes, transaction valuations, or financial ratios, so portfolio-level trend analysis is not possible from this set. The only substantive signal is governance-related: a senior hospital operations executive with a long operational track record is joining the board, which may modestly strengthen clinical and operational representation at the board level. Because the two filings describe the same event with overlapping details, they should be treated as one development rather than two independent data points. Investors should monitor subsequent disclosures for any financial or strategic follow-through rather than reacting to these notices alone.

2 medium 2 total filings
· daily

India SEBI Regulatory Enforcement Actions — October 27, 2026

Across the seven filings, the dominant theme is divergence between headline earnings recovery and underlying fragility. Max Financial Services (filings 1 and 6) shows year-on-year growth in profit after tax (Rs. 100.30 Cr vs Rs. 5.91 Cr) and consolidated total income (Rs. 11,605.21 Cr vs Rs. 9,798.62 Cr), but sequential declines in revenue from operations (Rs. 14,976.61 Cr to ~Rs. 11,601 Cr), profit before tax (Rs. 137.92 Cr to Rs. 108.77 Cr) and total comprehensive income (Rs. 153.38 Cr to Rs. 60.50 Cr), reflecting volatile policyholder income in the life insurance subsidiary. Omaxe Limited shows a sharp year-on-year improvement in consolidated losses (Q2 loss of Rs. 25.55 Cr vs Rs. 166.42 Cr; H1 loss of Rs. 24.25 Cr vs Rs. 352.19 Cr) and total income up to Rs. 613.91 Cr from Rs. 346.36 Cr, but the company still carries a consolidated other-equity deficit of (Rs. 1,107.71 Cr) and a SAT-dismissed SEBI order. Triumph International Finance India is the clear outlier on the negative side: a 9/10 materiality filing with negative standalone net worth of Rs. (6,182.09) lakh, five auditor qualifications, a potential Rs. 367.02 crore impairment, and going-concern doubt after SEBI cancelled its broker registration and an NSE default. The enforcement picture is mixed: SEBI disposed of Max Financial's proceedings with no penalty, a SEBI adjudication order against Taurian MPS lacks quantum disclosure, and Samvardhana Motherson's USD 19,500 NYS WCB penalty on a US subsidiary was rescinded on appeal. Procedurally, EFC (I) Limited's demerger scheme was admitted by NCLT Mumbai with a final hearing set for November 27, 2026.

7 high priority 7 total filings